Finn Greg, Lu Kun Ping
Cancer Biology Program, Division of Hematology/Oncology, Department of Medicine, Beth Israel Deaconess Medical Center, Harvard Medical School, 77 Avenue Louis Pasteur, NRB 1030, Boston, MA 02115, USA.
Curr Cancer Drug Targets. 2008 May;8(3):223-9. doi: 10.2174/156800908784293622.
Proline directed phosphorylation is a key regulatory mechanism controlling the function of fundamental proteins involved in cell proliferation and oncogenic transformation. Recently, the identification of the phosphorylation dependent prolyl isomerase Pin1 has uncovered a distinct regulatory mechanism controlling protein function. Specifically, Pin1 controls the conversion of peptidyl proline bond conversion from cis to trans, only when the preceding serine or threonine is phosphorylated. The intrinsic inter-conversion of such bonds is rather slow and is further inhibited by phosphorylation. As a consequence catalysis by Pin1 is required to overcome this restriction. Importantly, structural evidence has now demonstrated that Pin1-catalyzed prolyl isomerization can have significant effects on the global structure of substrate proteins. Furthermore, Pin1 overexpression is found in several types of cancer where it functions to not only promote tumorigenesis induced by oncogenes such as Ras and Neu, but also to regulate molecules that facilitate persistent proliferative capacity. Consequently, Pin1-mediated phosphorylation-dependent isomerization represents a unique regulatory mechanism in cell signaling whose deregulation during tumorigenesis adds to the pro-proliferative capacity of tumor cells and therefore Pin1 represents a novel tumor marker and potential therapeutic target.
脯氨酸定向磷酸化是一种关键的调控机制,控制着参与细胞增殖和致癌转化的基础蛋白质的功能。最近,磷酸化依赖性脯氨酰异构酶Pin1的鉴定揭示了一种控制蛋白质功能的独特调控机制。具体而言,Pin1仅在前一个丝氨酸或苏氨酸被磷酸化时,控制肽基脯氨酸键从顺式到反式的转化。这种键的内在相互转化相当缓慢,并且会被磷酸化进一步抑制。因此,需要Pin1的催化来克服这种限制。重要的是,结构证据现已表明,Pin1催化的脯氨酰异构化可对底物蛋白的整体结构产生显著影响。此外,在几种类型的癌症中发现Pin1过表达,其作用不仅是促进由Ras和Neu等癌基因诱导的肿瘤发生,还调节有助于维持增殖能力的分子。因此,Pin1介导的磷酸化依赖性异构化代表了细胞信号传导中的一种独特调控机制,其在肿瘤发生过程中的失调增加了肿瘤细胞的促增殖能力,因此Pin1代表了一种新型肿瘤标志物和潜在的治疗靶点。